Larson Financial Group LLC Takes $116,000 Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Larson Financial Group LLC acquired a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) in the 4th quarter, HoldingsChannel reports. The fund acquired 8,162 shares of the company’s stock, valued at approximately $116,000.

Several other hedge funds and other institutional investors have also made changes to their positions in TAK. XY Capital Ltd lifted its stake in Takeda Pharmaceutical by 432.5% in the fourth quarter. XY Capital Ltd now owns 765,137 shares of the company’s stock worth $10,919,000 after acquiring an additional 621,440 shares during the last quarter. FMR LLC lifted its stake in Takeda Pharmaceutical by 4.7% in the third quarter. FMR LLC now owns 2,593,350 shares of the company’s stock worth $40,119,000 after acquiring an additional 115,947 shares during the last quarter. Brandes Investment Partners LP lifted its stake in Takeda Pharmaceutical by 2.1% in the third quarter. Brandes Investment Partners LP now owns 1,802,036 shares of the company’s stock worth $27,877,000 after acquiring an additional 36,717 shares during the last quarter. Citigroup Inc. lifted its stake in Takeda Pharmaceutical by 5.6% in the third quarter. Citigroup Inc. now owns 57,941 shares of the company’s stock worth $896,000 after acquiring an additional 3,089 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in shares of Takeda Pharmaceutical during the 3rd quarter worth approximately $2,105,000. Hedge funds and other institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Down 1.2 %

Shares of NYSE:TAK opened at $13.07 on Friday. The company has a market capitalization of $41.35 billion, a PE ratio of 19.80, a P/E/G ratio of 3.02 and a beta of 0.53. The company has a current ratio of 1.06, a quick ratio of 0.55 and a debt-to-equity ratio of 0.64. Takeda Pharmaceutical Company Limited has a twelve month low of $13.05 and a twelve month high of $17.11. The firm has a 50 day simple moving average of $14.09 and a 200-day simple moving average of $14.21.

Takeda Pharmaceutical (NYSE:TAK) last issued its quarterly earnings data on Thursday, February 1st. The company reported $0.51 earnings per share for the quarter. The business had revenue of $7.52 billion during the quarter. Takeda Pharmaceutical had a net margin of 6.90% and a return on equity of 12.57%. On average, equities analysts predict that Takeda Pharmaceutical Company Limited will post 1.5 EPS for the current fiscal year.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.